Mizuho raises Cardinal Health stock target to USD 280.00
Published on 10/23/2026 at 11:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRevenue and contract context
- Mizuho raised its Cardinal Health target from USD 250.00 to USD 280.00 on October 21, 2026.
- Fiscal 2026 revenue reached USD 254.2 billion, up 14 percent from the previous year.
- Cardinal Health stock traded at EUR 228.35 at 11:12 a.m. CEST at Lang & Schwarz on October 23, 2026.
Cardinal Health stock (ISIN US14149Y1082) was trading at EUR 228.35 at Lang & Schwarz on October 23, 2026, at 11:12 a.m. CEST. Mizuho raised its price target from USD 250.00 to USD 280.00 on October 21, 2026, according to MarketBeat.
Target increase follows a strong year
The new target came after Cardinal Health reported fiscal 2026 revenue of USD 254.2 billion, a 14 percent increase from USD 222.6 billion in fiscal 2025. Operating earnings reached USD 2.6 billion, up from USD 2.3 billion a year earlier, according to Distribution Strategy Group.
The latest annual figures show the core trade remains a low-margin, high-volume business. Operating earnings represented about 1.03 percent of fiscal 2026 revenue, based on the reported USD 2.6 billion and USD 254.2 billion totals.
What does the CVS extension mean?
Cardinal Health entered a binding letter of intent on October 1, 2026, to extend its pharmaceutical distribution relationship with CVS Health through June 30, 2032. CVS accounted for 28 percent of fiscal 2026 revenue, making the agreement material for volume visibility, according to Distribution Strategy Group.
Three events set the recent sequence
On August 11, 2026, Cardinal Health reported fourth-quarter revenue of USD 63.7 billion and fiscal 2026 results through its newsroom. On October 1, 2026, the company disclosed the CVS extension through June 30, 2032. On October 21, 2026, Mizuho lifted its target from USD 250.00 to USD 280.00 while maintaining an outperform rating, as MarketBeat reported.
Next date is November 5
The next scheduled reporting event is Cardinal Health's first-quarter fiscal 2027 results on November 5, 2026, before trading begins on the New York Stock Exchange, according to the Cardinal Health Newsroom.
Stock stays tied to execution
The higher target reflects confidence in earnings growth and the durability of Cardinal Health's distribution relationships. The counterweight is concentration: CVS represented 28 percent of fiscal 2026 revenue, so execution and renewal terms remain important to the operating picture.
Cardinal Health was trading at EUR 228.35 at Lang & Schwarz on October 23, 2026, at 11:12 a.m. CEST.
The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.
Cardinal Health stock facts
- Company: Cardinal Health, Inc.
- ISIN: US14149Y1082
- Ticker: CAH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 23, 2026, 11:12 a.m. CEST): EUR 228.35
- Market capitalization: USD 59.2 billion (as of October 22, 2026)
- 52-week range: USD 158.70-259.21 (as of October 22, 2026)
- Sector / Industry: Healthcare / Medical - Distribution
- Next earnings date: November 5, 2026
Market context: Market report S&P 500.
